#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    CDKL5 deficiency disorder Advanced systemic mastocytosis Myeloid leukaemia Pneumonia Prodromal Alzheimer's disease Cryoglobulinaemia Vernal keratoconjunctivitis Amyotrophic lateral sclerosis gene carrier Hereditary motor and sensory neuropathy Lymphatic malformation Anal cancer Acute myeloid leukaemia recurrent Haemolytic uraemic syndrome Netherton's syndrome Neuromyelitis optica spectrum disorder More trials…

    Learn about Rare Diseases

    Skin angiosarcoma – Life with Disease Sjogren’s syndrome – Treatment Mast cell activation syndrome – Basic Information Prolymphocytic leukaemia – Life with Disease X-linked lymphoproliferative syndrome – Basic Information Haemophilia B without inhibitors – Basic Information Hairy cell leukaemia recurrent – Trials in Disease VEXAS syndrome – Trials in Disease Mantle cell lymphoma stage IV – Basic Information Paroxysmal nocturnal haemoglobinuria – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Crisantaspase Wve-006 Ciltacabtagene Autoleucel Tin816 Bgb-15025 Citrate RNMB1 Varegacestat Esketamine Salbutamol Sulfate Secukinumab Aspartic Acid Art0380 Mesilate MORPHINE HRS 9531 Evg321 Terbinafine Hydrochloride Tildrakizumab Microcrystalline Cellulose Chlortalidone Ro7269162 More therapies…

    Learn about Your Condition

    Pre-eclampsia Retinal neovascularisation CADASIL Lymphatic malformation Ehlers-Danlos syndrome Hypoglycaemia Gender dysphoria Hypomagnesaemia Intestinal ischaemia Metastatic gastric cancer Cutaneous lupus erythematosus Acromegaly Brain abscess Oesophagogastroscopy Nervous system disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • A study of tovorafenib for children and young adults with newly diagnosed or recurrent craniopharyngioma

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Craniopharyngioma
    Investigated Drugs:
    • Tovorafenib
    France Germany The Netherlands

  • A study on the effects of support and music during psilocybin therapy for people with depression.

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Depression
    Investigated Drugs:
    • Dry Extract From Psilocybe Cubensis (15-25:1), Extraction Solvent: Methanol
    Denmark

  • A study to compare two different dosing methods of tocilizumab in patients with rheumatoid arthritis who have low disease activity or are in clinical remission

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Tocilizumab
    France

  • Comparing low-dose and standard-dose argatroban or enoxaparin to prevent blood clots in patients with heart or lung failure receiving extracorporeal membrane oxygenation.

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Argatroban Monohydrate
    • Enoxaparin Sodium
    Czechia

  • A study to evaluate the safety and effectiveness of resomelagon in patients with polymyalgia rheumatica who are in remission using glucocorticoids

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Polymyalgia rheumatica
    Investigated Drugs:
    • Resomelagon
    Denmark

  • Comparison of dupilumab and tezepelumab for the treatment of chronic rhinosinusitis with nasal polyps.

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic rhinosinusitis with nasal polyps
    Investigated Drugs:
    • Tezepelumab
    • Dupilumab
    Austria
Previous Page
1 … 731 732 733 734 735 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!